Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2022-08-08 Major Shareholding Noti…
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease due to market sales) by LB Investment in the company ToolGen. This type of filing is used to notify the market of significant changes in shareholding percentages, which falls under the 'Major Shareholding Notification' category.
2022-08-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their shareholdings and changes therein, which corresponds to the 'Director's Dealing' category.
2022-08-04 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identified as a '정정신고' (Amendment Report). It details changes to previously reported stock option grants due to employee departures. This type of filing, which reports on changes to capital-related instruments (stock options) and is submitted to regulatory bodies like the Financial Services Commission/Korea Exchange, falls under the category of regulatory filings for capital changes or miscellaneous corporate disclosures. Given the specific nature of the filing (amendment to stock option grants), it fits best under 'Regulatory Filings' (RNS) as it is a formal disclosure of a corporate action.
2022-06-29 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company 'ToolGen' (주식회사 툴젠) covering the period from 2022-01-01 to 2022-03-31. It contains detailed corporate information, business descriptions, and financial data structures typical of a formal quarterly filing submitted to the Financial Services Commission and the Korea Exchange. It is not an announcement of a report, but the report itself. Q1 2022
2022-05-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and stock option grants for an executive (Lee Jae-young) of ToolGen. This type of filing is a standard regulatory requirement for insider holdings, which falls under the 'Director's Dealing' category.
2022-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to directors and employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation falls under the 'Share Issue/Capital Change' category.
2022-03-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.